{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/657a4abc8417640016c14413?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Thursday, December 14, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1702513312089-c19cb24cebcf737fe7bff670738cdba0.jpeg?height=200","description":"<p>The Supreme Court agrees to review a lower federal court ruling that could curtail access to mifepristone…a key drug used in medication abortions.&nbsp;Massachusetts will remove stigmatizing mental health and prior drug use questions from its physician credentialing process. And, Nemours will launch a pediatric hospital-at-home program in 2024.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}